1 |
Liam CK, Lim KH, Wong CMM. Community-acquired pneumonia in patients requiring hospitalization. Respirology. 2001; 6: 259-264.
DOI
ScienceOn
|
2 |
American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia. Am J Respir Crit Care Med. 2001; 163: 1730-1754.
DOI
|
3 |
Carlos M, Angela, Alejandro J, et al., Community -acquired pneumonia. Chest. 2000; 118: 1344-1354.
DOI
ScienceOn
|
4 |
Sopena N, Sabri M, Pedro-Botet ML, et al., Prospective study of community-acquired pneumonia of bacterial etiology in adults. Eur J Clin M icrobiol Infect Dis. 1999; 18: 852-858.
DOI
ScienceOn
|
5 |
Friedrich, Medizinische, Kliniken, et al., Intrevenous/Oral sequential therapy in patients hospitalised with communityacquired pneumonia. Drugs. 2002; 62: 303-317.
|
6 |
Bartlett JG, Dowell SF, Mandell LA, File Jr TM, Musher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis. 2000; 31: 347-82
DOI
ScienceOn
|
7 |
Fine MJ, Auble TE, Yealy DM, et al., A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997; 336: 243-50
DOI
ScienceOn
|
8 |
유철웅, 박정원, 황병연 등. 노인환자에서의 원외폐렴. 대한 감염학회지. 2000; 32: 212-218.
|
9 |
정문현, 신완식, 김양리 등. 7개 대학 병원에서 조사한 지역 사회 폐렴의 원인균. 대한감염학회지. 1997; 29: 339-359.
|
10 |
Fine MJ, Stone RA, Singer DE, et al., Processes and outcomes of care with community-acquired pneumonia: results from the pneumonia patient outcomes research team (PORT) cohort study. Arch Intern Med. 1999; 159: 970-980.
DOI
ScienceOn
|
11 |
Johnson PD, Irving LB, Turnidge JD. 3: Communityacquired pneumonia. Med J Aust. 2002; 176: 341-347.
|
12 |
Cantrill SV, Dalsey WC, Decker WW, et al., Clinical policy for the management and risk stratification of community-acquired pneumonia in adults in the emergency department. Ann Emerg Med. 2001; 38: 107-113.
DOI
ScienceOn
|
13 |
Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandevoot MK, Feagan BG. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. JAMA. 2000; 283: 749-755.
DOI
ScienceOn
|
14 |
배중훈, 이미진, 오동렬 등. 폐렴중증지수를 이용한 폐렴환자의 중증도 분류의 제안. 대한응급의학회지. 2002; 13: 129-134.
|
15 |
Flanders WD, Tucker G, Krishnadasan A, et al., Validation of the pneumonia severity index. Importance of studyspecific recalibration. Gen Intern Med. 1999; 14: 333-340.
DOI
|
16 |
윤지호, 이동채, 이한슬 등. 목포지역에서의 지역사회 획득 폐렴의 임상적 연구. 결핵 및 호흡기질환. 2001; 51: 17-24.
|
17 |
Ruiz M, Arosio C, Salman P, Bauer TT, Torres A. Diagnosis of pneumonia and monitoring of infection eradication. Drugs 2000; 60: 1289-1302.
DOI
ScienceOn
|
18 |
Kaplan V, Angus DC, Griffin MF, Clermont G, Scott Watson R, Linde-Zwirble WT. Hospitalized communityacquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med. 2002; 165: 766-772.
DOI
ScienceOn
|
19 |
Stuble SP, Reichlin S, Dieterle T, Leimenstoll B, Schoenenberger R, Martina B. Community-acquired pneumonia--which patients are hospitalised? Swiss Med Wkly. 2001; 131: 188-192.
|
20 |
Halm EA, Switzer GE, Mittman BS, Walsh MB, Chang CC, Fine MJ. What factors influence physicians' decisions to switch from intravenous to oral antibiotics for community-acquired pneumonia? J Gen Intern Med. 2001; 16: 599-605.
DOI
ScienceOn
|
21 |
Fine MJ, Pratt HM, Obrosky DS, et al., Relation between length of hospital stay and costs of care for patients with community-acquired pneumonia. Am J Med. 2000; 109: 378-385.
DOI
ScienceOn
|
22 |
Ruiz M, Ewig S, Torres A, et al., Severe communityacquired pneumonia. Risk factors and follow-up epidemiology. Am J Respir Crit Care Med. 19991; 160: 923-929.
DOI
|
23 |
Hoe LK, Keang LT. Hospitalized low-risk communityacquired pneumonia: Outcome and potential for costsavings. Respirology. 1999; 4: 307-309.
DOI
ScienceOn
|
24 |
Leroy O, Devos P, Guery B, et al., Simplified prediction rule for prognosis of patients with severe communityacquired pneumonia in ICUs. Chest. 1999; 116: 157-165.
DOI
ScienceOn
|
25 |
Lovering AM, MacGowan AP, Anderson P, Irwin D. Epidemiology and resource utilization for patients hospitalized for lower respiratory tract infection. Clin Microbiol Infect. 2001; 7: 666-670.
DOI
ScienceOn
|
26 |
Lim WS, Macfarlane JT, Boswell TC, et al., Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax. 2001; 56: 296-301.
DOI
ScienceOn
|
27 |
Marras TK, Gutierrea C, Chan CK. Applying a prediction rule to identify low-risk patients with community-acquired pneumonia. Chest. 2000; 118: 1339-1343.
DOI
ScienceOn
|
28 |
Ruiz M, Ewig S, Marcos MA, et al., Etiology of communityacquired pneumonia: Impact of age, comorbidity, and severity. Am J Respir Crit Care Med. 1999; 160: 397-405.
DOI
ScienceOn
|
29 |
Feagan BG, Marrie TJ, Lau CY, et al., Treatment and outcomes of community-acquired pneumonia at Canadian hospitals. CMAJ. 2000; 162: 1415-1420.
|
30 |
Feldman C, Viljoen E, Morar R, et al., Prognostic factors in severe community-acquired pneumonia in patients without co-morbid illness. Respirology. 2001; 6: 323-330.
DOI
ScienceOn
|